Xeomin incobotulinumtoxinA regulatory update

The Scottish Medicines Consortium recommended the use of Merz's Xeomin incobotulinumtoxinA on the National Health Service (NHS) in Scotland to treat post-stroke spasticity of the upper limb presenting...